Your browser doesn't support javascript.
loading
Flavin Adenine Dinucleotide-Related Adverse Event Necessitating Cardiopulmonary Resuscitation in an Infant.
Fujii, Shunsuke; Tetsuhara, Kenichi; Imamura, Suzu; Muraoka, Mamoru; Suzuki, Sayo.
Afiliación
  • Fujii S; Department of Critical Care Medicine, Fukuoka Children's Hospital, Fukuoka, JPN.
  • Tetsuhara K; Department of Critical Care Medicine, Fukuoka Children's Hospital, Fukuoka, JPN.
  • Imamura S; Department of Critical Care Medicine, Fukuoka Children's Hospital, Fukuoka, JPN.
  • Muraoka M; Department of Pediatric Cardiology, Fukuoka Children's Hospital, Fukuoka, JPN.
  • Suzuki S; Department of Pediatric Cardiology, Fukuoka Children's Hospital, Fukuoka, JPN.
Cureus ; 14(2): e22143, 2022 Feb.
Article en En | MEDLINE | ID: mdl-35308717
Mitochondrial rescue drugs, such as vitamin B2, are a treatment modality which can be considered in unexplained cases of cardiac arrest or impaired consciousness in which mitochondrial diseases are considered in the differential. Although case reports exist of children developing a drop in their blood pressure following administration of intravenous flavin adenine dinucleotide (FAD) sodium as vitamin B2, we present the first reported case of a child requiring cardiopulmonary resuscitation (CPR) following FAD sodium infusion for severe bradycardia and hypotension. Intravenous infusion of FAD sodium should be administered as slowly as possible, with careful monitoring of blood pressure and heart rate.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Cureus Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Cureus Año: 2022 Tipo del documento: Article